It is now well established that stromal interaction molecule 1 (STIM1) is the calcium sensor of endoplasmic reticulum stores required to activate store-operated calcium entry (SOC) channels at the surface of non-excitable cells. However, little is known about STIM1 in excitable cells, such as striated muscle, where the complement of calcium regulatory molecules is rather disparate from that of non-excitable cells. Here, we show that STIM1 is expressed in both myotubes and adult skeletal muscle. Myotubes lacking functional STIM1 fail to show SOC and fatigue rapidly. Moreover, mice lacking functional STIM1 die perinatally from a skeletal myopathy. In addition, STIM1 haploinsufficiency confers a contractile defect only under conditions where rapid refilling of stores would be needed. These findings provide insight into the role of STIM1 in skeletal muscle and suggest that STIM1 has a universal role as an ER/SR calcium sensor in both excitable and non-excitable cells.
STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle Store-operated calcium entry (SOC) is a well established mechanism for refilling internal calcium stores in many cell types. Replenishing internal calcium stores depends on an endoplasmic reticulum (ER) calcium sensor that was recently identified as STIM1 (refs 1, 2). STIM1 is a single-pass transmembrane phosphoprotein located in the membrane of the ER, where it interacts with SOC channels in the plasma membrane 3 . After release of stored calcium, STIM1 molecules sense internal store depletion and aggregate at sites within the ER (called punctae) in close proximity (10-15 nm) to SOC channels located in the plasma membrane [4] [5] [6] . STIM1 punctae thus function as crucial links between internal calcium stores and SOC channels on the plasma membrane 7 . STIM1-dependent SOC is important for many cell processes, including calcium-dependent gene expression.
STIM1 influences the activity of several different types of calcium channels, including store-operated (Orai1 and TRPC1/4) and receptor-operated (TRPC3/6 and ARC) channels 8 . Orai1 was shown to be required for store-operated calcium entry by genome-wide screens, and STIM1 is needed to activate Orai channels 9, 10 Recent work has also identified several transient receptor potential (TRP) channels and arachidonate-regulated (ARC) channels as STIM1-regulated channels that are activated following agonist stimulation in non-excitable cells 11, 12 . Orai (CRACM) family members (Orai1-3) form highly selective calcium channels with the characteristics of calcium-release-activated calcium currents (I crac ) when co-expressed with STIM1. In contrast, Orai channels co-expressed with STIM2 show both store-operated and store-independent gating 13 . Orai1 may also exist in a complex with TRP channels (TRPC1) where, together, STIM1, Orai1 and TRPC1 form store-operated channels, as has been described in epithelial cells of salivary glands 14 . STIM1 has also been shown to influence TRPC1-channel gating through a direct interaction that requires the carboxyterminal ERM (exrin/radixin/moesin) or Lys-rich region 12, 15 . Finally, STIM1 can also influence other TRPC channels through an indirect mechanism that requires TRPC1, as silencing of STIM1 reduced the TRPC3 currents 12 . Thus, it seems clear that STIM1 is required as part of a more general mechanism to activate plasma membrane calcium entry channels of several types.
Although substantial evidence supports the crucial role of STIM1 signalling in regulating SOC in non-excitable cells, far less is known about SOC in excitable cells, such as striated muscle, where large fluctuations in cellular calcium are required for muscle contraction 16 . This requires excitation-contraction (EC) coupling, a process by which changes in the membrane potential evoke calcium release from sarcoplasmic reticulum (SR) stores in response to stimulation of the ryanodine receptor (Ryr) channel Ryr1. Refilling of internal stores for EC coupling was previously thought to occur exclusively through re-sequestration of calcium by the highly efficient calcium pumps (SERCA) located in the SR membrane 17 . However, SOC was recently shown to exist in myofibres where it can be activated rapidly in response to store depletion 18 . It is thought that the fundamental role of SOC in muscle is to refill internal calcium stores and prepare the myofibre for subsequent muscle contraction 19 . Defects in muscle SOC channels are believed to cause muscle fatigue and exercise intolerance 20 . However, we recently proposed that SOC is also necessary to maintain NFAT transactivation during both muscle development and the remodelling response to exercise 19, 21 . In this context, we hypothesize that NFAT transactivation through sustained SOC confers a form of memory to the trained muscle of recent neurostimulation. The identification of STIM1 as the sensor of calcium-store depletion allowed for the generation of a genetic model to test our hypothesis that SOC provides a pool of calcium required not only for skeletal muscle contraction, but also for muscle development and remodelling.
RESULTS

STIM1 regulates NFAT-dependent myogenesis
We pursued studies of STIM1 to assess a previously unrecognized role for this protein in skeletal muscle, where SOC is necessary for NFAT translocation and NFAT signalling is known to be important in myogenesis and in adaptation to exercise 19, 22, 23 ( Supplementary Information,  Fig. S1a ). We first analysed the spatial and temporal expression pattern for STIM1 during myogenesis. We found that STIM1 is expressed at low levels in myoblasts, but that its expression is increased after differentiation into multinucleated myotubes (Fig. 1a) . Interestingly, STIM1 redistributes from a perinuclear localization in myoblasts to the cell periphery of differentiated myotubes (Fig. 1b, c) . This localization of STIM1 near the plasma membrane seems to occur under basal conditions even when stores are fully loaded with calcium, unlike the redistribution of STIM1 to the cell periphery following store depletion in non-excitable cells 4, 24 . STIM1 redistribution seems to be a unique feature of myotubes and ; P < 0.001, Fig. 1d, e) . In addition, myotubes overexpressing a wild-type or a constitutively active form of STIM1 (ref. 1) showed an increase (2.5-and 4.5-fold, respectively) in basal NFAT transactivation when compared with myotubes expressing endogenous STIM1 or myotubes in which STIM1 expression was silenced using a short hairpin (sh) RNA plasmid directed against mouse Stim1 ( Supplementary Information, Fig. S1b-d ). These data suggest that differentiation signals upregulate STIM1 in skeletal myotubes which is correlated with greater SOC. Moreover, myotubes overexpressing wildtype STIM1 or a constitutively active form of STIM1 (D76A) showed enhanced NFAT-dependent transcriptional regulation during myogenesis ( Supplementary Information, Fig. S1b ).
Calcineurin/NFAT signalling controls morphogenetic events of muscle formation, which occur around embryonic day 15.5 (E15.5; refs [25] [26] [27] . Stim1 mRNA expression increases in the embryo starting at E7.5 to E15.5; during this period morphogenic events that are controlled by NFAT transactivation also occur ( Supplementary Information,  Fig. S2a) . A STIM1-specific probe detected Stim1 mRNA by in situ hybridization in the embryonic limbs and brain at E16.5 ( Supplementary  Information, Fig. S2b-d) , whereas the sense (control) probe failed to detect any signal (Supplementary Information Fig. S2c-e) . Thus, results of these in vitro and in vivo studies indicate that STIM1 may have a relevant role in muscle differentiation.
Gene trap of STIM1 results in a loss-of-function model
We next established a loss-of-function model for STIM1 using a genetrap approach that results in expression of a STIM1-LacZ fusion protein under the control of the endogenous Stim1 promoter (ES cell line RRS558; Fig. 2a-c) . STIM1-LacZ leaves the amino-terminal sterile α motif (SAM) and EF hand domains of the native STIM1 protein intact, but disrupts the ERM coiled-coiled domains that are required for SOC activation 15, 28 . Localization of STM1-LacZ in Stim1 +/gt heterozygous mice can thus be used to determine which cells express endogenous STIM1. We detected STIM1-LacZ in all muscle groups that were obtained from Stim1 +/gt heterozygous mice, Purkinje neurons of the cerebellum and in a selected subset of spleen and thymus cells ( Supplementary Information,  Fig. S3a-e Fig. 2e-f ). These studies demonstrate that the mutation in Stim1 results in a loss-of-function model.
STIM1 regulates SOC currents in muscle cells
We analysed the properties of SOC currents (I soc ) in primary myotubes isolated from Stim1 +/+ , Stim1 +/gt and Stim1 gt/gt mice using whole-cell patch-clamp recording. For these studies, we used solutions and protocols that are standard for recording I soc in other cells 29, 30 and SOC was activated by depleting calcium stores with the SERCA antagonist thapsigargin (2 µM, Fig. 3a (Fig. 3d , e), which is consistent with the ion selectivity profile of SOC channels 32 . Moreover, changing the external solution from one containing 2 mM Ca 2+ to a divalent-free solution resulted in a large increase in the current amplitude (278% of control, Fig. 3d -e), indicating an increase in the permeability of monovalent cations in the absence of Ca 2+ , which is another hallmark of SOC currents. Finally, myotube SOC currents were inhibited by the trivalent cation Gd 3+ (10 µM, Fig. 3d -e) and the SOC inhibitor SKF96365 (10 µM, data not shown). These findings suggest that SOC currents recorded from Stim1 +/+ myotubes are similar to calcium release-activated calcium (CRAC) currents recorded from many non-excitable cells 33, 34 . The linear currents that were recorded from a subset of myotubes suggest that, in addition to (classic) CRAC-like SOC currents, other plasmamembrane currents may also be activated following store depletion in skeletal myotubes. Although the nature of these currents is unknown, future studies to further characterize the currents activated by store depletion in skeletal myotubes will more fully define the mechanism(s) underlying SOC in these excitable cells. It is possible, for example, that the observation of a linear current in some myotubes and an inwardly rectifying current in other myotubes may reflect differences in the complement of channels that are activated by store depletion in these two populations of myotubes and may also reflect differences in SOC currents between excitable cells and non-excitable cells.
STIM1 localizes to the muscle SR
We next examined the localization of STIM1 in skeletal muscle from the hindlimbs of adult mice. Immunostaining for STIM1 using two independent antibodies showed a striated pattern that partially colocalized with the Ryr channels that are known to be present at the terminal cisternae ( Fig. 4a-c ). These studies suggest that STIM1 may localize to the skeletal myofibre SR. We next examined STIM1 expression in subcellullar fractions of rabbit skeletal muscle. Isolated microsomal fractions were obtained using sucrose gradients and showed STIM1 expression in fractions corresponding to the t-tubule, longitudinal SR, and the terminal cisternae (Fig. 4f) . We also examined the expression of STIM1-LacZ by electron microscopy ( Fig. 4d-e) .
Aggregates of the reaction products of β-galactosidase were detected in the longitudinal SR as well as the junction of the t-tubule and terminal cisternae. STIM1-LacZ aggregates were detected in most, but not all, foot processes, which is probably because we examined only Stim1 +/gt muscles. These results provide insight into the structure of the SOC complex in muscle and may explain differences in SOC kinetics, compared with non-excitable cells that we and others have observed in myofibres 35 .
Mice lacking a functional STIM1 die of skeletal myopathy
We next carried out a series of studies to investigate how the loss of STIM1 affects skeletal muscle structure and function. mice showed a marked reduction in the muscle cross-sectional area, compared with Stim1 +/+ mice ( Fig. 5a-b) . Ultrastructural analysis of the tibialis anterior (TA) muscle of Stim1 gt/gt mice using transmission electron microscopy revealed markedly swollen mitochondria in the subsarcolemmal and intramyofibrillary space, compared with control Stim1
). These ultrastructural abnormalities in muscles of Stim1 gt/gt mice were also associated with altered expression of muscle-specific proteins in the SR and sarcomere (Fig. 6a ). There was a marked decrease in the expression of SERCA1 and myosin heavy chain in hindlimb muscles from Stim1 gt/gt neonatal mice, supporting the histological evidence of muscle damage.
Based on these indications of muscle pathology, we hypothesized that the perinatal lethality in Stim1 gt/gt is due to a congenital myopathy. To test our hypothesis, we assessed the physical and functional characteristics of skeletal muscle from Stim1 +/gt mice as well. Sarcomeric architecture was basically preserved: foot processes seemed to be intact and the weights, lengths and single twitch contractions of isolated extensor digitorum longus (EDL) muscles evoked with stimulation at 60 and 80 mV were not different between 8-week-old Stim1 +/gt and Stim1 +/+ mice (data not shown). However, force-frequency measurements of isolated EDL muscles 36 showed an inability of Stim1+/gt muscles to generate the same level of tetanic force as Stim1 +/+ mice ( Fig. 6d-e) . Moreover, EDL muscles isolated from Stim1 +/gt mice showed a marked reduction in the time to fatigue, compared with those taken from Stim1 +/+ mice (24 ± 4.7 s versus 35.6 ± 0.5 s, P < 0.002, Fig. 6f ). Taken together, these results suggest that muscles from Stim1 +/gt mice have severe defects in force generation and fatigue resistance, and support the notion that neonatal STIM1-mutant mice manifest significant muscle weakness.
Myotubes lacking STIM1 manifest fatigue
Refilling of internal calcium stores following membrane depolarization has long been recognized to occur through the rapid action of SERCA located in the longitudinal SR 37 . However, recent evidence that SOC is required to refill internal stores has implicated it in the regenerative calcium oscillations observed in muscle and suggests that SOC is required to prevent muscle fatigue 20 . Calcium oscillations in myotubes depend in part on calcium entry and may function in regulating gene expression during muscle differentiation 21, 38, 39 . We therefore examined KCl-evoked calcium transients from myotubes responded to subsequent KCl pulses with a minor decrement in calcium transient amplitude (Fig. 7a-d) . At the end of each KCl stimulation protocol, we measured the SR calcium store content by depleting stores with thapsigargin (2 µM) and caffeine (10 mM) and found that Stim1 +/gt and Stim1 gt/gt myotubes showed significant defects in refilling of internal stores, compared with Stim1 +/+ myotubes (Fig. 7e) . These results indicate that SOC is needed to refill internal calcium stores in a muscle that is subjected to repeated stimulation, to prepare for the next depolarization.
DISCUSSION
In this study, we provide evidence that mice carrying mutant STIM1 have defects in muscle differentiation and contractile activity. We found that neonatal mice lacking functional STIM1-dependent SOC died from a perinatal myopathy and that haploinsufficiency of STIM1 in adult mice confered increased susceptibility to fatigue. These findings support a model where STIM1 is required to activate SOC and refill internal stores in myotubes in response to signals associated with muscle differentiation and in myofibres subjected to increased motor-nerve activity. Although the precise signals are not known at present, it is likely that STIM1-mediated SOC is important for both short-term calcium responses, that is, muscle contraction, and long-term responses, such as a remodelling through calcium-dependent gene expression.
We also provide evidence that STIM1 is essential for myotube development and that loss of STIM1 causes defective SOC, which underlies defective muscle differentiation both in vitro and in vivo. STIM1 expression increased during myotube differentiation and correlated with increased SOC activity in myotubes, compared with myoblasts. STIM1-dependent SOC is important for NFAT-dependent gene expression, as shown by STIM1 gain-and loss-of-function studies in C2C12 cells. It is also likely that STIM1-dependent store-refilling is important to maintain calcium oscillations that are needed for muscle differentiation 40 . For example, Stim1 gt/gt myotubes failed to show SOC in response to thapsigargin-induced SR store depletion or in response to repeated KCl pulses. Moreover, Stim1 +/+ myotubes exposed to a series of depolarizing signals maintained full calcium stores, whereas Stim1 gt/gt myotubes failed to refill their stores. These results suggest that STIM1 is important for store-refilling after calcium release from Ryr1-containing calcium stores by membrane depolarization, which is important for muscle differentiation 41 .
In mature muscle, we found that STIM1 haploinsufficiency confers a contractile defect only under conditions of increased contractile H-Ryr binding. Complete scans of these gels are shown in Supplementary Information, Fig. S6 ).
demand, where calcium store depletion is most likely to occur. Under these conditions of increased muscle usage, STIM1 haploinsufficiency probably results in ineffective sensing of store depletion that occurs with high-frequency stimulation, thus resulting in a defect in force generation and early fatigue. In the present study we were unable to determine whether the increased fatigue results from defective refilling of Ryr1-containing calcium stores or from a developmental defect. We did find, however, that levels of SERCA1 and myosin heavy chain expression were reduced in muscles from Stim1 gt/gt mice. Reduced expression of either of these proteins may cause reduced muscle performance. Taken together, these studies of STIM1-mutant mice indicate that SOC is an important calcium signalling pathway in muscle, operating to refill calcium stores needed for muscle contraction.
We found that STIM1 is localized to the muscle SR where calcium is released by Ryr1 and refilled by SERCA1. In fact, STIM1 localizes to both the foot process and longitudinal SR. It is possible, therefore, that SOC is important in muscle to augment EC coupling, through a mechanism in which STIM1 senses the depletion of Ryr stores with augmented contractile activity, activates SOC channels in the t-tubule membrane, and thus increases calcium-store refilling. In this way, STIM1 may function as a sensor of contractile stress. According to this model, muscles under ambient conditions would cycle calcium through the Ryr calcium stores in a rapid fashion; however under conditions of increased motor-nerve activity, muscles would activate STIM1-dependent SOC to rapidly refill internal stores. SOC would provide a sustained increase in subsarcolemmal calcium that would set in motion a series of remodelling events aimed at optimizing muscle performance. This muscle remodelling may include upregulation of TRPC3 expression that serves to augment SOC with subsequent bouts of exercise 19 . Interestingly, recent reports suggest that STIM1 can interact with TRPC1 and indirectly with TRPC3 channels to mediate SOC in diverse cell types 12, 15, 42, 43 . The findings presented here provide the first genetic evidence for essential physiological functions of SOC in skeletal muscle and validate a conceptual model in which SOC confers cellular memory of recent motornerve activity. In this way, STIM1-dependent SOC in muscle provides a mechanism that sustains increases in the cytosolic calcium concentration to preserve contractile function during repeated contractions and to activate calcium-dependent signalling events that underlie remodelling responses associated with neurostimulation. SOC has been recognized as a mechanism of calcium overload in skeletal myopathies, such as muscle dystrophy [44] [45] [46] . However, the only physiological functions known to date for STIM1 and Orai1 have been shown by mutations in the human Orai1 gene, where a defect in SOC causes severe combined immunodeficiency, and in Caenorhabditis elegans mutants, where mutations in Stim1 and Orai homologues cause abnormal gut function and infertility 47, 48 . However, one patient with a mutation in Orai1 also manifested a skeletal myopathy that may involve impaired calcineurin/ NFAT signalling 3 . Moreover, Orai1 reporter mice show the robust expression of Orai1 in mature skeletal muscle 49 . Here we provide direct evidence that loss of STIM1 in mice produces a skeletal myopathy. Taken together, these results indicate that STIM1 participates in a conserved calcium signalling network that is active in diverse cell types that use calcineurin signalling to respond to changing environmental stimuli.
METHODS
Cell culture. C2C12 cells were propagated in Dulbecco's modified Eagle's medium (DMEM)-low glucose, supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (100 U ml -1 ). C2C12 differentiation from myoblasts to myotubes took place over 5 days while incubated in differentiating medium containing DMEM-high glucose containing 2% horse serum, 10 µg ml -1 transferrin, 10 µg ml -1 insulin, 50 mM HEPES buffer pH 7.4, 100 U/ ml -1 penicillinstreptomycin. Experiments involving C2C12 cells were performed after 5 days in differentiating medium except when otherwise noted. Primary myoblasts were isolated from Stim1
, and Stim1 +/+ neonates by collagenase digestion using a previously described protocol 50 and subsequently allowed to differentiate into myotubes, as described above for C2C12 cells.
Intracellular Ca
2+ imaging. C2C12 cells were plated on 0.1% gelatin-coated glass coverslips at least 12 h before imaging. Imaging of myotubes was performed after transferring cells to differentiating medium for 5 days. Ca 2+ imaging was performed with a ×40 objective on an automated fluorescence microscope with a Photometrics CoolSnap camera. C2C12 cells were loaded with 10 µM fura-2-acetoxymethyl ester in extracellular buffer (140 mM NaCl, 2.8 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM glucose and 10 mM Hepes) for 30 min at room temperature while shielded from light. Fura-2 fluorescence was measured by illuminating the cells with an alternating 340/380 nm light every 1-2 s and fluorescent images were captured at 510 nm. Changes in intracellular Ca 2+ concentration were derived from changes in the ratio of fluorescence intensity at 340 and 380 nm. For Ca 2+ addback experiments, C2C12 cells were bathed in Ca 2+ -free medium (140 mM NaCl, 2.8 mM KCl, 4 mM MgCl 2 , 10 mM glucose, 10 mM HEPES and 10 mM EGTA) and then treated with thapsigargin (2 µM) and verapamil (10 µM), followed by Ba 2+ (2 mM) after Ca 2+ store depletion. Immunhistochemistry. C2C12 cells were fixed as myoblasts or myotubes with ice-cold methanol at -20 °C for 10 min. Immunostaining with an anti-STIM1 antibody (BD Biosciences) was performed at a dilution of 1:100. Images were obtained with a ×40 objective on Zeiss-LSM 510 META fluorescence microscope and analysed with MetaMorph software (Universal Imaging). For immunofluorescence microscopy studies of muscle tissues, muscles were frozen in OCT and then cryosectioned. Images were obtained using a ×40 objective on a Zeiss LSM 510 inverted confocal microscope. Rabbit anti-Ryr1 antibody was obtained from Gerhard Meissner (University of North Carolina, Chapel Hill).
Whole-cell patch-clamp recordings. Patch-clamp experiments were performed to record currents in the whole-cell mode with pipettes filled with solutions containing 137 mM caesium aspartate, 2 mM CsCl, 8 mM MgSO 4 , 15 mM HEPES, 12 mM BAPTA, pH 7.2 (with CsOH), 310 mOsm (with d-Mannitol). The external solution consisted of 150 mM NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, 20 mM sucrose, pH 7.4 (with NaOH), 320 mOsm(with d-mannitol); in NMDG solution, Na + was replaced an with equivalent concentration of NMDG; in Ba 2+ solution, Ca 2+ replaced by Ba
2+
; in divalent-free solution, Ca
and Mg 2+ were omitted and 10 mM EDTA was added. To block the L-type Ca 2+ channel, verapamil (10 µM) was added to the external solutions; K + channels were blocked by adding Cs + in the internal solution and the voltage-dependent Na + channel was inactivated by the stimulation protocol. The osmolarity of each solution was verified with a freezing-point osmometer (Advanced Instruments). Voltage across the cell-attached membrane patch was controlled and currents recorded using an Axonpatch-200A amplifier with Digidata 1200 interface and analysed with pCLAMP software. Currents were induced by 200 ms voltage ramp protocols every 2 s (1 mV ms -1
, from 100 mV to -100 mV), at a holding potential 0 mV. Experiments were performed at room temperature with a sample rate of 4 kHz (filter 2 kHz). For analysis of I soc , the first ramps before activation of SOC currents (usually 1-3) were pooled and used for leak-subtraction of all subsequent current recordings.
Antibodies and western blotting. Cell extracts were prepared by washing the cells with PBS and then extracting proteins with lysis buffer: PBS, 5 mM EDTA, 5 mM EGTA, 1 mM sodium vanadate, 10 mM sodium pyrophosphate, 50 mM sodium fluoride, and 1% Triton X-100. Proteins were resolved on SDS-polyacrylamide gels and electroblotted onto nitrocellulose membranes (Amersham Biosciences, Hybond-C Extra). After transfer, nitrocellulose membranes were blocked for 1 h at room temperature in 5% milk with Tris-buffered saline/Tween 20 (TBST): 10 mM Tris HCl, pH 8.0, 150 mM NaCl, 0.1% Tween 20. Next, the membranes were incubated overnight at 4 °C with an anti-STIM1 primary antibody (BD Biosciences) diluted 1:250 with 1% milk in TBST. After washing with TBST, membranes were incubated at room temperature for 1 h with a secondary antibody (1:200; Jackson Laboratories). Peroxidase activity was detected with enhanced chemiluminescence (Amersham Biosciences, ECL advance western blotting detection kit). SERCA1 and MyoD antibodies were obtained from Affinity Bioreagents. Unless otherwise stated, equal loading was confirmed by immunoblotting with an antitubulin antibody (1:200; (Santa Cruz).
Stim1 gene silencing. DNA templates for the synthesis of silencing RNA were cloned into an expression plasmid for subsequent transfection. The coding sequence for targeting Stim1 mRNA was selected using the siRNA Target Finder and Design Tool from Ambion. The potential target sequence was subjected to a BLAST search against mouse EST libraries to ensure specificity of the target. The oligonucleotide sequences were: si-4 construct, sense, 5´-GACCTCAATTACCATGACC-3´, antisense, 3´-CTGGAGTTAATGGTACTGG-5´; si-6 construct, sense, 5´-CCGTTACTCTAAGGAGCAC-3´, antisense 3´-GGCAATGAGATTCCTCGTG-5´. C2C12 myocytes were transfected using Fugene reagent (Roche).
STIM1-targeted mice. The ES cell line RRS558 from BayGenomics was generated by using a gene-trap protocol with pGT0Lxf vector containing the engrailed 2 gene and β-galactosidase-neomycin-resistance fusion protein. A comparison between the BayGenomics database and the NCBI UniGene database suggested that the insertion site for this gene-trap construct is in exon 8 of Stim1, which corresponds to a fusion protein consisting of the extracellular and transmembrane domain of STIM1 with a β-galactosidase protein on the N terminus. A PCR-based strategy was used to map the exact location that the gene-trap construct inserted into the Stim1 gene. Genotyping of littermates using tail-digest genomic DNA first involved amplifying the LacZ gene to identify the mice with a targeted allele ) showed a reduction in SERCA1 (top panel) and myosin heavy chain (MHC, middle panel) in mutant STIM1 mice as assessed by immunoblotting with specific antibodies for SERCA1 and MHC (MF20). Quantification using densitometry is provided for studies of three mice for each genotype for SERCA1 (b) and MHC (c). Complete scans of these gels can be found in Supplementary  Information, Fig. S6 and then a second round of PCR using primers specific to the insertion site of the gene-trap construct was performed to identify homozygous mice.
β-galactosidase staining. All mouse tissues were dissected in cold PBS and immediately fixed with 4% PFA at 4 °C for 1 h. After rinsing the tissues with rinsing solution (5 mM EGTA, 0.01% deoxycholate, 0.02% NP40, 2 mM MgCl 2 ) 3 times for 15 min at room temperature, the tissues were incubated in the dark with staining solution (5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 5 mM EGTA, 0.01% deoxycholate, 0.02% NP40, 2 mM MgCl 2 , 1 mg ml -1 X-gal solution) at 37 °C until the desired intensity was reached. The specimens were then washed with PBST, post-fixed with 4% PFA overnight and stored in 70% EtOH. Paraffin sectioning of the stained organs was performed using standard methods and subsequently stained with haematoxylin and eosin (H&E). For electron microscopy of Stim1 gt/+ muscle, samples were post-fixed in 2% PFA and 2% glutaraldehyde in 0.1 M cacodylate buffer pH 7.4 for 12 h. Sections were fixed in 1% OSO 4 and embedded in an epoxy resin mixture. Ultrathin sections were studied with an EM 410 electron microscope (Phillips). For control experiments Stim1 +/+ samples were processed as above.
Skeletal muscle contractility and fatigability. Stim1
+/gt and Stim1 +/+ control mice were anaesthetized with pentobarbitone (10 mg, intraperitoneally) and intact EDL muscles were removed and placed in Krebs buffer (pH 7.4). The intact whole muscles were placed in a 30-ml chamber between platinum stimulatingelectrodes and bathed in Krebs buffer, which was continuously aerated with 95% O 2 . The force transducer measurements were recorded and analysed on computer using Polyview software (Grass). Muscles were subjected to multiple frequencies of stimulation of 200 ms duration to produce the force-frequency relationship. Muscles were fatigued by stimulation at the frequency which produces maximum tetanic force, as well as submaximal frequencies, at 1-s intervals for 5 min while recording the changes in force production over time. All animal studies were performed under an approved IACUC protocol. 
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Figure S4
Membrane currents from primary muscle cells. Myotubes were prepared from STIM1 +/+ , STIM1 +/gt and STIM1 gt/gt mice and currents recorded using whole cell patch clamp (as described in Methods section). A) Time course for currents from STIM1 +/+ , STIM1 +/gt and STIM1 gt/gt myotubes are shown for +80 mV and -80 mV. Myotubes were stimulated with thapsigargin 2µM followed by gadolinium 100 µM. B) Current-voltage relationships are shown for the current recorded in (A) at the labeled points (a-d respectively). C) Group mean changes of peak I soc at -80mV and +80mV for myotubes from STIM1 +/+ , STIM1 +/gt and STIM1 gt/gt mice. * indicates p<0.05.
